Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients
Articolo
Data di Pubblicazione:
2021
Abstract:
In patients with metastatic non–clear cell renal cell carcinoma, the combination of cytoreductive nephrectomy and systemic therapy confers better survival, with respect to single treatments alone or no treatment.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cytoreductive nephrectomy; Histological subtypes; Metastases; Non–clear cell renal cell carcinoma; Overall mortality; Systemic therapy
Elenco autori:
Luzzago, S.; Palumbo, C.; Rosiello, G.; Knipper, S.; Pecoraro, A.; Mistretta, F. A.; Tian, Z.; Musi, G.; Montanari, E.; Soulieres, D.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I.
Link alla scheda completa:
Pubblicato in: